Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.22 +0.61 (+0.82%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Assets (2017 - 2026)

Updated

Kiniksa Pharmaceuticals International's Other Non-Current Assets was $10.83 million in Q2 2026, up 32.2% from $8.2 million a year earlier but down 2.9% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Assets (2017 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Assets at Kiniksa Pharmaceuticals International came in at $11.31 million, up 9.6% from FY2024.

  • Other Non-Current Assets shows a five-year compound annual growth rate of 15.1% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Assets was $10.32 million in FY2024, $827,000 in FY2023 (-85.8%), $5.82 million in FY2022 (-33.2%) and $8.72 million in FY2021 (+56.0%).
  • Quarterly Other Non-Current Assets has moved between $827,000 (Q4 2023) and $11.31 million (Q4 2025) over five years.
  • Compared with a year earlier, Other Non-Current Assets has increased for six straight quarters, with growth averaging 61.2% over the last seven quarters.
  • The best year-over-year quarter for Other Non-Current Assets over five years was Q3 2024 (growth of 242.3%); the worst was Q4 2023 (a decline of 85.8%).
  • Per Business Quant data, KNSA's Other Non-Current Assets in the three quarters before Q2 2026 was $11.16 million (Q1 2026), $11.31 million (Q4 2025) and $8.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Kiniksa Pharmaceuticals International 11.64 Bn 10.38 Bn 220.03 Mn 10.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.83 Mn
Mar 31, 2026 11.16 Mn
Dec 31, 2025 11.31 Mn
Sep 30, 2025 8.29 Mn
Jun 30, 2025 8.20 Mn
Mar 31, 2025 8.20 Mn
Dec 31, 2024 10.32 Mn
Sep 30, 2024 7.85 Mn
Jun 30, 2024 7.90 Mn
Mar 31, 2024 4.13 Mn
Dec 31, 2023 827,000.00
Sep 30, 2023 2.29 Mn
Jun 30, 2023 2.35 Mn
Mar 31, 2023 2.32 Mn
Dec 31, 2022 5.82 Mn
Sep 30, 2022 5.63 Mn
Jun 30, 2022 5.67 Mn
Mar 31, 2022 5.92 Mn
Dec 31, 2021 8.72 Mn
Sep 30, 2021 6.55 Mn
API Access

Kiniksa Pharmaceuticals International Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KNSA&period=max&api_key=YOUR_API_KEY